About 1 in 6 people deal with infertility. For plenty of them, IVF becomes the path forward. Most conversations focus on the egg: how many you retrieve, the quality, whether they fertilise. But here's the thing. Sperm matters equally.
Sperm DNA damage has been linked to worse IVF outcomes. Lower implantation rates. Fewer pregnancies. This is why newer technologies like microfluidics for sperm selection are getting attention.
The name sounds like science fiction. The concept is straightforward. Microfluidics is a technology in which very small amounts of fluid move through tiny channels inside a specially designed device, a chip. In fertility, these channels recreate conditions sperm naturally experience travelling through the female reproductive tract. Like a miniature obstacle course.
A semen sample contains millions of sperm. Not all of them are equally healthy. Not all can successfully fertilise an egg. Sperm selection isn't about finding any sperm. It's about finding sperm with good movement and potentially lower DNA damage.
Microfluidic selection uses sperm's natural movement and behaviour to separate higher-quality sperm from the rest. Traditional methods rely heavily on centrifugation. Microfluidic systems don't. That's one reason IVF and ICSI labs are interested in the technology.
When people think IVF, they think about the egg. It gets retrieved. It gets fertilised. It becomes an embryo. That's only half the story.
During conventional IVF or ICSI, embryologists need to pick sperm with the best characteristics for fertilisation. Labs traditionally use swim-up or density gradient centrifugation, and they have been using these methods for years. They work. But they focus on what you can see or measure: movement, density. They don't always identify sperm with intact DNA.
And that matters. Sperm can look perfect under a microscope and still carry DNA damage. Research connects elevated DNA fragmentation to worse assisted reproduction outcomes. The relationship is complex, though. High fragmentation doesn't make pregnancy impossible. Researchers have been trying to make sperm selection more precise because of this.
The device has microscopic channels, and the semen sample is introduced into them. Instead of separating by density, the system uses sperm movement and the physical environment inside the chip. Healthy motile sperm navigate the channels better. Less motile sperm don't make it through. Basically, the sperm select themselves.
This mimics what happens naturally. During normal conception, not all sperm reach the egg. The reproductive tract creates physical and biological barriers, and only a small fraction actually gets there. Microfluidics tries to replicate those natural selection principles in a controlled lab environment. Depending on the device, the mechanisms involve sperm motility, fluid flow, and other biological properties.
Maybe. It depends on what you mean by better. Microfluidics doesn't find the perfect sperm. It can't guarantee IVF success. What it does is enrich the sample with sperm showing characteristics linked to better reproductive potential.
Research shows microfluidic selection can produce:
A 2025 systematic review of 39 studies found microfluidic selection significantly reduced DNA fragmentation. It also showed improvements in motility and morphology compared to conventional methods, along with improvements in clinical pregnancy and some live birth measures. Here's where you have to be careful, though.
Better sperm parameters don't automatically mean a baby.
Some studies reported encouraging results. Others found no statistically significant pregnancy or live birth improvements. A 2026 randomised controlled trial with 119 couples found microfluidic sorting reduced DNA fragmentation better than density-gradient centrifugation, especially in samples with high baseline fragmentation. But there were no significant differences in clinical pregnancy, ongoing pregnancy, or live birth rates. So the technology is promising. Researchers are still figuring out which patients actually benefit.
This is the biggest reason microfluidics gets attention. DNA fragmentation is damage or breaks in the genetic material sperm carries. Sperm can look normal, have a good shape, good movement, and still have damaged DNA.
Why care? Sperm contributes half the genetic material to the embryo. That half matters. Studies link higher DNA fragmentation to worse reproductive outcomes. The relationship is complex, and high fragmentation doesn't make pregnancy impossible.
Microfluidic selection can help because it favours highly motile sperm and potentially sperm less affected by DNA damage. One study compared microfluidic selection with density-gradient centrifugation in paired samples. Microfluidic-selected sperm showed a 0% median DNA fragmentation index. The density-gradient samples showed 6%. Encouraging results. But that doesn't mean every patient gets the same outcome.
Not automatically, and not for everyone. Swim-up and density-gradient centrifugation are well-established, widely used, and still effective. Microfluidics is better thought of as an additional option, not a replacement for everything.
The choice depends on sperm quality, past IVF outcomes, DNA fragmentation levels, fertility history, and what your fertility centre offers. For patients concerned about DNA fragmentation or sperm-quality parameters, an embryologist might consider microfluidics as part of the strategy.
Most couples want a straight answer. The honest answer: maybe. It can't be guaranteed. Recent research is promising. The 2025 meta-analysis found improvements in lab and reproductive outcomes. At the same time, other reviews found that evidence for improved pregnancy and miscarriage outcomes is still limited or statistically inconclusive.
This tells you something important about fertility treatment: one factor rarely determines the outcome. Everything influences IVF success:
Microfluidics isn't magic. It's a promising technology that might help embryologists make sperm selection more physiologically relevant and more targeted.
Certain IVF or ICSI situations call for it, particularly when there are concerns about sperm quality or DNA fragmentation. It's worth discussing with your specialist if there is:
That doesn't mean every IVF patient needs it. The right approach is always personalised. Your fertility specialist and embryology team assess your specific situation and decide whether an advanced method fits.
Microfluidics is still evolving, and that's exciting. Researchers are exploring increasingly sophisticated systems that could select based on multiple biological characteristics, not just one parameter. They are also exploring microfluidics across different assisted reproduction stages: sperm preparation, fertilisation, and embryo procedures.
The goal is simple: make the IVF lab better at replicating natural reproduction processes. That is valuable when every sperm and every egg matters.
Microfluidics sounds complicated. The purpose is straightforward: help embryologists identify and collect potentially higher-quality sperm using a more natural, precise process.
By using sperm movement and microscopic fluid channels, microfluidic selection reduces exposure to the stresses of conventional processing and might select sperm with lower DNA fragmentation. Research is encouraging, especially for DNA fragmentation and motility. It's important to remember, though, that promising technology doesn't equal guaranteed results. More large-scale, high-quality clinical research is needed to determine when microfluidics provides the greatest benefit.
For couples doing IVF, don't pick the newest technology just because it's new. Understand what's actually appropriate for your fertility journey. Better IVF care isn't always about doing more. It's about selecting the right approach at the right time.
Schedule a consultation with our expert team at MMC IVF. We are here to provide personalized care and support.
MMCIVF and Zivanza Wellness are trademarks and tradenames owned by MUrgency Inc., USA.
Services listed on the MMCIVF.com website are available in each Country we provide services in through MMCIVF Affiliated Clinics licensed, regulated and supervised by the Competent Authorities in the respective Country and based on the applicable laws, rules and regulations in the respective Country / Jurisdiction.
MMCIVF operates Clinics in each Country as aforesaid above under the laws, rules and regulations of the respective Country. All patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Clinics and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents are expected to be fully compliant with the laws, rules and regulations in the respective Country and of any other jurisdiction they (the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents) are subject to. MMCIVF Country / MMCIVF Country Directors / MMCIVF Country Doctors / MMCIVF Country Nurses / MMCIVF Country Staff / MMCIVF Country Agents cannot and will not take any responsibility and / or liability for compliance or non-compliance of any law, rule or regulation outside the respective Country where treatment is sought and provided which is solely the responsibility of the patients / prospective patients / consultees / prospective consultees and / or anyone interacting with MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents.
Further, MMCIVF Country and / or MMCIVF Country Directors and / or MMCIVF Country Doctors and / or MMCIVF Country Nurses and / or MMCIVF Country Staff and / or MMCIVF Country Agents will not solicit and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India to Indian Citizens / Residents (whether in India or outside India) strictly following this as MMCIVF Country policy recognizing and respecting applicable Indian Laws, Rules, and Regulations. All Indian Citizens / Residents are advised to ensure that they fully comply with the applicable Indian Laws, Rules, and Regulations while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. MMCIVF Country shall not take any responsibility whatsoever for any violation of any applicable Indian Laws, Rules, and Regulations by any Indian Citizen / Resident while reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country which sole responsibility shall vest with such Indian Citizens / Residents reaching out / interacting / communicating / consulting / taking treatment with MMCIVF Country. In case any individual / agency / firm / company reaches out to any Indian Citizen / Resident for and on behalf of MMCIVF Country for any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India, please be known that we have not authorized any staff member / individual / agency / firm / company to reach out to Indian Citizens / Residents (whether in India or outside India) to offer and / or support any family balancing and / or sex determination and / or any prohibited medical procedure in India and / or any prohibited medical treatment in India. If you are aware of any such reach outs and / communication, please inform MMCIVF Country at info@mmcivf.ae immediately so that we can take remedial measures against such reach outs claiming to represent MMCIVF Country.
Further, MMCIVF in each Country operates independently and separately from other MMCIVF Clinics in Other Countries.
NOTE: Please read Country as respective Country – USA, Kenya, Georgia and United Arab Emirates as appropriate, relevant and applicable.